• 908 Citations
20092020
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

The goal of Dr. Penaloza's research is to understand the basic mechanisms of immune regulation and to use this information to develop vaccines and regimens against chronic infections, such as HIV and HCV, as well as cancers.

Training Experience

2014Postdoctoral Fellowship, Beth Israel Deaconess Medical Center

Education/Academic qualification

PhD, Emory University

… → 2011

Research interests

  • AIDS
  • HIV Infection
  • Immune Regulation
  • Infectious Diseases
  • Microbiology
  • Vaccine Science
  • Virology

Fingerprint Dive into the research topics where Pablo Penaloza-MacMaster is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
T-Lymphocytes Medicine & Life Sciences
Lymphocytic choriomeningitis virus Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Adenoviridae Medicine & Life Sciences
T-lymphocytes Agriculture & Biology
Regulatory T-Lymphocytes Medicine & Life Sciences
Simian Immunodeficiency Virus Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2015 2020

Virus Diseases
Regulatory T-Lymphocytes
T-Lymphocytes
Infection
Antigens
HIV Antibodies
Antibody Formation
Research
HIV
Acquired Immunodeficiency Syndrome
AIDS Vaccines
HIV
T-Lymphocytes
Vaccines
Lymphocytic choriomeningitis virus
Organized Financing
Financial Management
Research
Publications
Neoplasms

Research Output 2009 2019

  • 908 Citations
  • 30 Article
  • 1 Short survey
  • 1 Review article

TLR4 signaling improves PD-1 blockade therapy during chronic viral infection

Wang, Y., Chung, Y. R., Eitzinger, S., Palacio, N., Gregory, S., Bhattacharyya, M. & Penaloza-MacMaster, P., Feb 1 2019, In : PLoS pathogens. 15, 2, e1007583.

Research output: Contribution to journalArticle

Open Access
Virus Diseases
Cell Death
Lipopolysaccharides
T-Lymphocytes
Dendritic Cells
1 Citation (Scopus)

Adenovirus vector vaccination impacts NK cell Rrheostat function following lymphocytic choriomeningitis virus infection

Blass, E., Aid, M., Martinot, A. J., Larocca, R. A., Kang, Z. H., Badamchi-Zadeh, A., Penaloza-MacMaster, P., Reeves, R. K. & Barouch, D. H., Jun 1 2018, In : Journal of virology. 92, 11, e02103-17.

Research output: Contribution to journalArticle

Lymphocytic choriomeningitis virus
natural killer cells
Adenoviridae
Virus Diseases
Natural Killer Cells

Combined HDAC and BET inhibition enhances melanoma vaccine immunogenicity and efficacy

Badamchi-Zadeh, A., Moynihan, K. D., Larocca, R. A., Aid, M., Provine, N. M., Justin Iampietro, M., Kinnear, E., Penaloza-MacMaster, P., Abbink, P., Blass, E., Tregoning, J. S., Irvine, D. J. & Barouch, D. H., Nov 1 2018, In : Journal of Immunology. 201, 9, p. 2744-2752 9 p.

Research output: Contribution to journalArticle

Histone Deacetylases
Melanoma
Interleukin-6
T-Lymphocytes
Vaccines
Lymphocytic choriomeningitis virus
Virus Diseases
Bone Marrow Transplantation
Transplantation
Lymphocytes
1 Citation (Scopus)

Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells

Nakashima, H., Alayo, Q. A., Penaloza-Macmaster, P., Freeman, G. J., Kuchroo, V. K., Reardon, D. A., Fernandez, S., Caligiuri, M. & Chiocca, E. A., Dec 1 2018, In : Scientific reports. 8, 1, 208.

Research output: Contribution to journalArticle

Glioblastoma
Immunity
T-Lymphocytes
Neoplasms
Programmed Cell Death 1 Receptor